Omeros Corporation (OMER)
Nasdaq: OMER · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 2004
Who runs Omeros Corporation
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Demopulos Gregory A Md
Chairman, CEO & President. First filing Oct 2009, latest Oct 30, 2026, 6 filings in all.
Officers reporting now
3
of 11 people with a filing in the last fifteen months
Directors reporting now
8
15 people on the record since 2009
Officerssales are open-market, Oct 30, 2025 to Oct 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Demopulos Gregory A Md | Chairman, CEO & President | Oct 2009 | Oct 30, 2026 | none |
| Borges David J. | VP, Finance & CAO | Jul 2024 | Sep 24, 2026 | 7 · $1.5M |
| Cancelmo Peter B | VP, General Counsel | Jun 2019 | Sep 1, 2026 | 2 · $900,000 |
Directorssales are open-market, Oct 30, 2025 to Oct 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hanish Arnold C | director | Sep 2012 | Aug 28, 2026 | 3 · $300,000 |
| Cable Thomas J. | director | Oct 2009 | Aug 21, 2026 | 2 · $400,000 |
| Schocken Joseph L | director | Aug 2026 | Aug 18, 2026 | none |
| Bumol Thomas F. | director | Feb 2019 | Jun 22, 2026 | none |
| Demopulos Peter A Md | director | Oct 2009 | Jun 22, 2026 | none |
| Hood Leroy E. Md Phd | director | Oct 2009 | Jun 22, 2026 | none |
| Perkinson Diana T. | director | May 2023 | Jun 22, 2026 | none |
| Shah Rajiv | director | Jun 2015 | Jun 22, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.